The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of the world’s #1 cause of disability Rey Pascual, Vivex’s Co-President, added, “The strength of a rigorous sham-controlled trial marks a defining…
Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology MIAMI & SEOUL, South Korea--(BUSINESS WIRE)--$SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) and Lunit Inc. (KRX: 328130) today announced a…
Research presented by LRA, LT, and collaborators will address some of the most significant challenges in lupus, including reducing barriers to clinical trial participation, improving trial design and outcome assessment, evaluating molecular signatures associated with disease severity and treatment response,…
New sites in the UK, France, Sweden, Germany, Italy and Spain will add to the global footprint of the pivotal SIGMA study Study site locations will be listed on ClinicalTrials.gov and updated as finalized. In August 2026, the FDA granted…
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE)…
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. PharmaTher Builds Portfolio of Personalized,…
Lead FDA-track program targets a serious pediatric disease with no FDA-approved treatment and could qualify for a transferable priority review voucher. Highlights Two FDA designation applications submitted for creatine monohydrate in guanidinoacetate methyltransferase (GAMT) deficiency: Orphan Drug Designation (ODD) and…
US pharma major Bristol Myers Squibb (NYSE: BMY) reported third-quarter revenue of $13,069 million, up 7% from a year earlier, while adjusted earnings fell 17% to 135 cents a share. Revenue growth was...
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. American Diabetes Month Celebrates What’s…
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. bioAffinity Technologies Highlights Importance of…
Biotech industry news from BioSpace, Endpoints News, Fierce Biotech, BioPharma Dive, BioWorld, BioCentury, Labiotech, GeneOnline, GenomeWeb and others.
An article joins this feed when it matches these terms. Each one is also a search of its own.